144 related articles for article (PubMed ID: 11103680)
1. [Cerebrospinal fluid protein tau levels in the differential diagnosis of Alzheimer's disease].
Schonknecht P; Pantel J; Werle E; Hartmann T; Essig M; Baudendistel K; Beyreuther K; Schroder J
Fortschr Neurol Psychiatr; 2000 Oct; 68(10):439-46. PubMed ID: 11103680
[TBL] [Abstract][Full Text] [Related]
2. Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study.
Hampel H; Buerger K; Zinkowski R; Teipel SJ; Goernitz A; Andreasen N; Sjoegren M; DeBernardis J; Kerkman D; Ishiguro K; Ohno H; Vanmechelen E; Vanderstichele H; McCulloch C; Moller HJ; Davies P; Blennow K
Arch Gen Psychiatry; 2004 Jan; 61(1):95-102. PubMed ID: 14706948
[TBL] [Abstract][Full Text] [Related]
3. Total tau in cerebrospinal fluid differentiates Alzheimer's disease from vascular dementia.
Leszek J; Małyszczak K; Janicka B; Kiejna A; Wiak A
Med Sci Monit; 2003 Nov; 9(11):CR484-8. PubMed ID: 14586274
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid markers in differential diagnosis of Alzheimer's disease and vascular dementia.
Boban M; Grbić K; Mladinov M; Hof PR; Süssmair C; Ackl N; Stanić G; Bader B; Danek A; Simić G
Coll Antropol; 2008 Jan; 32 Suppl 1():31-6. PubMed ID: 18405055
[TBL] [Abstract][Full Text] [Related]
5. Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease.
Arai H; Terajima M; Miura M; Higuchi S; Muramatsu T; Machida N; Seiki H; Takase S; Clark CM; Lee VM
Ann Neurol; 1995 Oct; 38(4):649-52. PubMed ID: 7574462
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic value of tau in cerebrospinal fluid in alzheimer disease].
Hu Y; He S; Wang J
Zhonghua Yi Xue Za Zhi; 2001 Nov; 81(22):1377-9. PubMed ID: 11930632
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid tau, Abeta1-42 and inflammatory cytokines in patients with Alzheimer's disease and vascular dementia.
Jia JP; Meng R; Sun YX; Sun WJ; Ji XM; Jia LF
Neurosci Lett; 2005 Jul 22-29; 383(1-2):12-6. PubMed ID: 15936505
[TBL] [Abstract][Full Text] [Related]
8. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid tau levels in Alzheimer's disease are elevated when compared with vascular dementia but do not correlate with measures of cerebral atrophy.
Schönknecht P; Pantel J; Hartmann T; Werle E; Volkmann M; Essig M; Amann M; Zanabili N; Bardenheuer H; Hunt A; Schröder J
Psychiatry Res; 2003 Oct; 120(3):231-8. PubMed ID: 14561434
[TBL] [Abstract][Full Text] [Related]
10. Tau protein in cerebrospinal fluid as an aid in the diagnosis of Alzheimer's disease.
Munroe WA; Southwick PC; Chang L; Scharre DW; Echols CL; Fu PC; Whaley JM; Wolfert RL
Ann Clin Lab Sci; 1995; 25(3):207-17. PubMed ID: 7605102
[TBL] [Abstract][Full Text] [Related]
11. Basic and clinical studies on the measurement of tau protein in cerebrospinal fluid as a biological marker for Alzheimer's disease and related disorders: multicenter study in Japan.
Nishimura T; Takeda M; Nakamura Y; Yosbida Y; Arai H; Sasaki H; Shouji M; Hirai S; Khise K; Tanaka K; Hamamoto M; Yamamoto H; Matsubayashi T; Urakami K; Adachi Y; Nakashima K; Toji H; Nakamura S; Yoshida H
Methods Find Exp Clin Pharmacol; 1998 Apr; 20(3):227-35. PubMed ID: 9646285
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?
Clark CM; Xie S; Chittams J; Ewbank D; Peskind E; Galasko D; Morris JC; McKeel DW; Farlow M; Weitlauf SL; Quinn J; Kaye J; Knopman D; Arai H; Doody RS; DeCarli C; Leight S; Lee VM; Trojanowski JQ
Arch Neurol; 2003 Dec; 60(12):1696-702. PubMed ID: 14676043
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid tau protein levels in demented and nondemented alcoholics.
Morikawa Y; Arai H; Matsushita S; Kato M; Higuchi S; Miura M; Kawakami H; Higuchi M; Okamura N; Tashiro M; Matsui T; Sasaki H
Alcohol Clin Exp Res; 1999 Apr; 23(4):575-7. PubMed ID: 10235290
[TBL] [Abstract][Full Text] [Related]
15. Subcortical vascular dementia biomarker pattern in mild cognitive impairment.
Bjerke M; Andreasson U; Rolstad S; Nordlund A; Lind K; Zetterberg H; Edman A; Blennow K; Wallin A
Dement Geriatr Cogn Disord; 2009; 28(4):348-56. PubMed ID: 19864909
[TBL] [Abstract][Full Text] [Related]
16. Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.
Hampel H; Teipel SJ; Fuchsberger T; Andreasen N; Wiltfang J; Otto M; Shen Y; Dodel R; Du Y; Farlow M; Möller HJ; Blennow K; Buerger K
Mol Psychiatry; 2004 Jul; 9(7):705-10. PubMed ID: 14699432
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cerebrospinal fluid tau/beta-amyloid(42) ratio as diagnostic markers for Alzheimer disease.
Smach MA; Charfeddine B; Ben Othman L; Lammouchi T; Dridi H; Nafati S; Ltaief A; Bennamou S; Limem K
Eur Neurol; 2009; 62(6):349-55. PubMed ID: 19786779
[TBL] [Abstract][Full Text] [Related]
18. Elevated interleukin-6 levels in cerebrospinal fluid of vascular dementia patients.
Wada-Isoe K; Wakutani Y; Urakami K; Nakashima K
Acta Neurol Scand; 2004 Aug; 110(2):124-7. PubMed ID: 15242421
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease.
Grossman M; Farmer J; Leight S; Work M; Moore P; Van Deerlin V; Pratico D; Clark CM; Coslett HB; Chatterjee A; Gee J; Trojanowski JQ; Lee VM
Ann Neurol; 2005 May; 57(5):721-9. PubMed ID: 15852395
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid tau and beta-amyloid in Alzheimer patients, disease controls and an age-matched random sample.
Ibach B; Binder H; Dragon M; Poljansky S; Haen E; Schmitz E; Koch H; Putzhammer A; Kluenemann H; Wieland W; Hajak G
Neurobiol Aging; 2006 Sep; 27(9):1202-11. PubMed ID: 16085339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
